Print

Evotec AG (EVTG.F) Becomes the First Contract Research Facility in Europe to Offer Agilent Technologies, Inc. (Santa Clara, California) (A)'s RapidFire/MS Screening for Pharmaceutical Drug Discovery  
5/16/2012 9:55:51 AM

HAMBURG, Germany, May 16, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities in Hamburg.
//-->